Abiraterone Acetate Treatment for Prostate Cancer Patients With a PSA of More Than Four Following Initial Androgen Deprivation Therapy Phase II
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2017
At a glance
- Drugs Abiraterone acetate (Primary) ; Degarelix; Goserelin; Leuprorelin; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 28 Oct 2016 Planned End Date changed from 1 Jul 2016 to 1 Oct 2018.
- 28 Oct 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Oct 2018.